Time is of the essence in establishing the diagnosis of stroke and determining whether the patient is a candidate for thrombolytic therapy, ideally initiated within the “golden hour” after arrival at ...

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...

Ischemic stroke is a major cause of death and disability, caused by a sudden loss of oxygen supply to the brain due to blocked blood vessels. Recanalization treatments such as intravenous thrombolysis ...

Key points A 68-year-old woman presented to the emergency department of a rural hospital in southern Alberta 1 hour after ...

A clotbusting drug commonly used to treat ischemic stroke interacts negatively with a promising anti-inflammatory treatment ...

Please provide your email address to receive an email when new articles are posted on . Societies issued new guidelines for the screening and treatment of stroke. The new document provides ...

Pregnancy and childbirth are usually filled with anticipation and hope. Modern obstetrics has dramatically improved the ...